350 rub
Journal №8 for 2013 г.
Article in number:
New polysulfones and their protection effects of gastric ulcers
Authors:
Yu.B. Vikhare, L.V. Anikina, M.N. Gorbunova
Abstract:
In the model of acute ulcers induced by acid ethanol, showing a protective effect of a dose-dependent α-LA and its tryptic hydrolyzate. Effect hydrolysates significantly higher than the native protein and is dependent on proteolytic exposure process. The most pronounced anti-ulcer effect in experiments with animals (rats) showed low molecular weight peptides derived from proteolysis long. Caused in an experimental model of acidified ethanol necrotic damage in the gastric mucosa was less or absent if the stomach 30 minutes before initiation of ulcers treated hydrolysates α-LA. The corresponding absolute patronage ulcer damage - the dose was for the native α-LA 280 mg / kg, for the most effective low molecular weight hydrolyzate III α-LA 2 mg / kg body weight of the animal. There is reason to believe that an important role in the mechanism of the protective action of peptides α-LA playing their antioxidant properties. Research has shown that during proteolysis α-LA formed hydrolysates antioxidant activity which correlates with their antiulcer effectiveness.
Pages: 53-57
References

  1. Marshall K. Therapeutic applications of whey protein // Altern Medicine Review. 2004. V. 9. № 2. P. 136-156.
  2. Kamau S.M., Cheison S. Ch., Chen W., Liu X-M., Lu R-R. Alpha - Lactalbumin: Its Production Technologies and Bioactive Peptides // Comprehensive Reviews in Food Science and Food Safety. 2010. V. 9. issue 2. P. 197-212
  3. Matsumoto H., Shimokawa Y., Ushida Y., Toida T., Hayasawa H. New biological function of bovine alpha-lactalbumin: protective effect against ethanol- and stress-induced gastric mucosal injury in rats // Biosci Biotechnol Biochem. 2001. V. 65. № 5. P. 1104-1111.
  4. Ushida Y., Shimokawa H., Matsumoto, Toida T., and Hayasawa H. Effects of bovine alpha-lactalbumin on gastric defense mechanisms in naive rats // Biosci Biotechnol Biochem. 2003. V. 67. № 3. P. 577-583.
  5. Lahiri S.H., Palit G. An overview or the current methodologies used for evatution of gastric and duodenal anti-ulcer agents // Pharmacologia. 2012. V. 3. № 8. P. 249-257.
  6. Wallace J.L., Sharkey K.A. Pharmacotherapy of Gastric Acidity, Peptic Ulcers and gastroesophageal replux Disease: Jn; The Pharmacological Basis of Therapeutics. L.L. Brunton, B.A. Chabner, Knollmann (eds). McGraw Hill. New York. 2011. P. 1309-1322.
  7. Holly M., Scott Algood, Timothy L. Cover. Helicobacter pylori Persistence: an Overview of interactions between H. pylori and host immune defenses // Clinical microbiology reviews. 2006. V. 19. № 4. P. 597-613.
  8. Shkitin V.A., Shpirna A.I., Starovojtov G.N. Rol' Helicobacter pylori v patologii cheloveka // Klinicheskaya mikrobiologiya i antimikrobnaya ximioterapiya. 2002. V. 4. № 2. P. 128-145.
  9. Vogel H.G. Antiulcer Activity. Jn: Drug Discovery and Evalution: pharmacological Assags. Springer-Verlag. Berlin. Germany. 2008. P. 1235-1240.
  10. Hernandez - Ledesma B., Davalos A., Bertolome B., Amigo L. Preparatioj of antioxidant enzymatic hydrolizates from α- lactalbumin and β-lactoglobulin. Identification of active peptides by HPLS-MS // Journal of Agricultural and Food Chemistry. 2005. V. 53. P. 588-593